N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway

References

• Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):1–14. doi: 10.1093/humrep/dew218.
   Web of Science ®Google Scholar
• Neven A, Laven J, Teede H, et al. A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin Reprod Med. 2018;36(1):5–12. doi: 10.1055/s-0038-1668085.
   PubMed Web of Science ®Google Scholar
• Teede H, Misso M, Costello M, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–1618. doi: 10.1093/humrep/dey256.
   PubMed Web of Science ®Google Scholar
• Glueck C, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108–120. doi: 10.1016/j.metabol.2018.11.002.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488. doi: 10.1016/j.fertnstert.2008.06.035.
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885–887. doi: 10.1038/nchembio.687.
   PubMed Web of Science ®Google Scholar
• Loos R, Yeo G. The bigger picture of FTO: the first GWAS-identified obesity gene. Nat Rev Endocrinol. 2014;10(1):51–61. doi: 10.1038/nrendo.2013.227.
   PubMed Web of Science ®Google Scholar
• Liu C, Mou S, Pan C. The FTO gene rs9939609 polymorphism predicts risk of cardiovascular disease: a systematic review and meta-analysis. PLoS One. 2013;8(8):e71901. doi: 10.1371/journal.pone.0071901.
   PubMed Web of Science ®Google Scholar
• Yang Y, Shen F, Huang W, et al. Glucose is involved in the dynamic regulation of m6A in patients with type 2 diabetes. J Clin Endocrinol Metab. 2019;104(3):665–673. doi: 10.1210/jc.2018-00619.
   PubMed Web of Science ®Google Scholar
• Sun X, Zhang Y, Hu Y, et al. Decreased expression of m6A demethylase FTO in ovarian aging. Arch Gynecol Obstet. 2021;303(5):1363–1369. doi: 10.1007/s00404-020-05895-7.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Wang Y, Li Z, et al. The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging. Cell Death Dis. 2021;12(8):744. doi: 10.1038/s41419-021-04016-9.
   PubMed Web of Science ®Google Scholar
• Liu A, Xie H, Xie H, et al. Association between fat mass and obesity associated (FTO) gene rs9939609 a/T polymorphism and polycystic ovary syndrome: a systematic review and meta-analysis. BMC Med Genet. 2017;18(1):89. doi: 10.1186/s12881-017-0452-1.
   PubMedGoogle Scholar
• Wang X, Wang K, Yan J, et al. A meta-analysis on associations of FTO, MTHFR and TCF7L2 polymorphisms with polycystic ovary syndrome. Genomics. 2020;112(2):1516–1521. doi: 10.1016/j.ygeno.2019.08.023.
   PubMed Web of Science ®Google Scholar
• Tan S, Scherag A, Janssen O, et al. Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). BMC Med Genet. 2010;11(1):12. doi: 10.1186/1471-2350-11-12.
   PubMedGoogle Scholar
• Kowalska I, Malecki M, Straczkowski M, et al. The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes. Diabetes Metab. 2009;35(4):328–331. doi: 10.1016/j.diabet.2009.03.004.
   PubMed Web of Science ®Google Scholar
• Di Pietro M, Parborell F, Irusta G, et al. Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model. Endocrinology. 2015;156(4):1453–1463. doi: 10.1210/en.2014-1765.
   PubMed Web of Science ®Google Scholar
• Andrade G, da Silveira J, Perrini C, et al. The role of the PI3K-Akt signaling pathway in the developmental competence of bovine oocytes. PLoS One. 2017;12(9):e0185045. doi: 10.1371/journal.pone.0185045.
   PubMed Web of Science ®Google Scholar
• Shen M, Jiang Y, Guan Z, et al. Protective mechanism of FSH against oxidative damage in mouse ovarian granulosa cells by repressing autophagy. Autophagy. 2017;13(8):1364–1385. doi: 10.1080/15548627.2017.1327941.
   PubMed Web of Science ®Google Scholar
• Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74(4):640–650. doi: 10.1016/j.molcel.2019.04.025.
   PubMed Web of Science ®Google Scholar
• Wei J, Liu F, Lu Z, et al. Differential m6A, m6Am, and m1A demethylation mediated by FTO in the cell nucleus and cytoplasm. Mol Cell. 2018;71(6):973–985.e975. doi: 10.1016/j.molcel.2018.08.011.
   PubMed Web of Science ®Google Scholar
• Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15. doi: 10.1016/j.fertnstert.2016.05.003.
   PubMed Web of Science ®Google Scholar
• Zhou L, Han X, Li W, et al. N6-methyladenosine demethylase FTO induces the dysfunctions of ovarian granulosa cells by upregulating flotillin 2. Reprod Sci. 2022;29(4):1305–1315. doi: 10.1007/s43032-021-00664-6.
   PubMed Web of Science ®Google Scholar
• Naessen T, Kushnir M, Chaika A, et al. Steroid profiles in ovarian follicular fluid in women with and without polycystic ovary syndrome, analyzed by liquid chromatography-tandem mass spectrometry. Fertil Steril. 2010;94(6):2228–2233. doi: 10.1016/j.fertnstert.2009.12.081.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhou W, Zhou C, et al. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2021;206:105806. doi: 10.1016/j.jsbmb.2020.105806.
   PubMed Web of Science ®Google Scholar
• Motahari Rad H, Mowla S, Ramazanali F, et al. Characterization of altered microRNAs related to different phenotypes of polycystic ovarian syndrome (PCOS) in serum, follicular fluid, and cumulus cells. Taiwan J Obstet Gynecol. 2022;61(5):768–779. doi: 10.1016/j.tjog.2022.05.013.
   PubMed Web of Science ®Google Scholar
• Yu L, Liu M, Wang Z, et al. Correlation between steroid levels in follicular fluid and hormone synthesis related substances in its exosomes and embryo quality in patients with polycystic ovary syndrome. Reprod Biol Endocrinol. 2021;19(1):74. doi: 10.1186/s12958-021-00749-6.
   PubMed Web of Science ®Google Scholar
• Svendsen P, Madsbad S, Nilas L, et al. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome. Int J Obes (Lond). 2009;33(11):1249–1256. doi: 10.1038/ijo.2009.165.
   PubMed Web of Science ®Google Scholar
• Magyar B, Santi M, Sommer G, et al. Short-Term fasting attenuates overall steroid hormone biosynthesis in healthy young women. J Endocr Soc. 2022;6(7):bvac075.
   PubMed Web of Science ®Google Scholar
• Huang X, Wu B, Chen M, et al. Depletion of exosomal circLDLR in follicle fluid derepresses miR-1294 function and inhibits estradiol production via CYP19A1 in polycystic ovary syndrome. Aging (Albany NY). 2020;12(15):15414–15435. doi: 10.18632/aging.103602.
   PubMedGoogle Scholar
• Panghiyangani, Roselina, Soeharso, Purnomo, Suryandari, Dwi Anita, et al. CYP19A1 gene expression in patients with polycystic ovarian syndrome. J Hum Reprod Sci 2020; 13(2):100–103. doi: 10.4103/jhrs.JHRS_142_18.
   PubMedGoogle Scholar
• Emami N, Moini A, Yaghmaei P, et al. Differences in expression of genes related to steroidgenesis in abdominal subcutaneous adipose tissue of pregnant women with and without PCOS; a case control study. BMC Pregnancy Childbirth. 2021;21(1):490. doi: 10.1186/s12884-021-03957-5.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ma X, Luo J, et al. Expression of serum PSA, nesfatin-1, and AMH in patients with polycystic ovary syndrome. Cell Mol Biol (Noisy-le-Grand). 2022;67(5):57–63. doi: 10.14715/cmb/2021.67.5.8.
   PubMed Web of Science ®Google Scholar
• Rudnicka E, Radowicki S, Suchta K. Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight. Gynecol Endocrinol. 2016;32(11):931–935. doi: 10.1080/09513590.2016.1200552.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhang J, Hu M, et al. In vivo differential expression patterns of glycolytic enzymes and mitochondria-dependent apoptosis in PCOS patients with endometrial hyperplasia, an early hallmark of ­endometrial cancer, and the impact of metformin. Int J Biol Sci. 2019;15(3):714–725. doi: 10.7150/ijbs.31425.
   PubMed Web of Science ®Google Scholar
• Zhou R, Li S, Liu J, et al. Up-regulated FHL2 inhibits ovulation through interacting with androgen receptor and ERK1/2 in polycystic ovary syndrome. EBioMedicine. 2020;52:102635. doi: 10.1016/j.ebiom.2020.102635.
   PubMed Web of Science ®Google Scholar
• Azumah R, Liu M, Hummitzsch K, et al. Candidate genes for polycystic ovary syndrome are regulated by TGFβ in the bovine foetal ovary. Hum Reprod. 2022;37(6):1244–1254. doi: 10.1093/humrep/deac049.
   PubMed Web of Science ®Google Scholar
• Palomba S, Piltonen T, Giudice L. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2021;27(3):584–618. doi: 10.1093/humupd/dmaa051.
   PubMed Web of Science ®Google Scholar